F18 allows doctors to "see" the plaques that cause Alzheimer's on a PET scan of a living brain. It was approved in the U.S. in April 2012 and has revolutionized the diagnosing of dementia. Learn how it works and why the European Union has followed the United States' lead.
Read more »